Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer

被引：0
|
作者：
M Shehata
A Al-Attar
J Reis-Filho
I Ellis
A Mukherjee
S Chan
机构：
[1] Nottingham University Hospital,The Breakthrough Breast Cancer Research Centre
[2] Institute of Cancer Research,undefined
来源：
Breast Cancer Research | / 12卷
关键词：
Breast Cancer; Breast Cancer Patient; Cyclophosphamide; Fluorouracil; Anthracyclines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Predictive markers of response to neoadjuvant chemotherapy in locally advanced breast cancer (LAPC)
    Mukherjee, A.
    Shehata, M.
    Sharma, R.
    Rakha, E.
    Ellis, I.
    Ball, G.
    Ball, B. M.
    Chan, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [33] Prospective Evaluation of Response Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Ashok, A.
    Sude, Nandkishor Sopanrao
    Rakesh, B. A.
    Karanam, Venkata Pavan Kumar
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [34] Induction of apoptosis predicts the response to the neoadjuvant chemotherapy in locally advanced breast cancer
    不详
    [J]. VIRCHOWS ARCHIV, 2005, 447 (02) : 366 - 366
  • [35] Tumour Characteristics Determining Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Turna, Z. Savas
    Ozturk, M. A.
    Tural, D.
    Biricik, F. S.
    Yildiz, O.
    Ozguroglu, M. A.
    Demirelli, F.
    Mandel, N. M.
    Buyukunal, E.
    Serdengecti, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S344 - S344
  • [36] Predictors of response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
    Parmar, V
    Nadkarni, M. S.
    Hawaldar, R.
    Shet, T.
    Nair, R.
    Gupta, S.
    Chinoy, R.
    Badwe, R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S172 - S173
  • [37] Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
    Brian M Nolen
    Jeffrey R Marks
    Shlomo Ta'san
    Alex Rand
    The Minh Luong
    Yun Wang
    Kimberly Blackwell
    Anna E Lokshin
    [J]. Breast Cancer Research, 10
  • [38] Circulating T cells and response to neoadjuvant chemotherapy in locally advanced breast cancer
    do Moura, J. F. P.
    Torres, L. C.
    Lima, V. C. C.
    Salles, A.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1214 - S1214
  • [39] Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
    Nolen, Brian M.
    Marks, Jeffrey R.
    Ta'san, Shlomo
    Rand, Alex
    Luong, The Minh
    Wang, Yun
    Blackwell, Kimberly
    Lokshin, Anna E.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (03):
  • [40] BASAL-LIKE PHENOTYPE IS A PROGNOSTIC MARKER OF LOCALLY ADVANCED BREAST CANCER BUT NOT A PREDICTIVE MARKER OF RESPONSE TO NEOADJUVANT ANTHRACYCLINE CHEMOTHERAPY
    Shehata, M.
    Mukherjee, A.
    Moseley, P.
    Rakha, E.
    Ellis, I.
    Chan, S.
    [J]. EJC SUPPLEMENTS, 2010, 8 (06): : 11 - 11
12345